Alerts will be sent to your verified email
Verify Email
HALDER
|
Halder Venture
|
Balaxi Pharma.
|
Parshva Enterprises
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.29 % | 29.33 % | 1.76 % |
|
5yr average Equity Multiplier
|
5.92 | 1.4 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
1.92 | 1.5 | 1.52 |
|
5yr Avg Net Profit Margin
|
0.81 % | 11.83 % | 0.98 % |
|
Price to Book
|
1.75 | 1.19 | 19.94 |
|
P/E
|
12.74 | 11.02 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
146.97 Days | 133.11 Days | 103.36 Days |
|
Inventory Days
|
72.12 Days | 68.7 Days | 63.35 Days |
|
Days Receivable
|
84.83 Days | 81.67 Days | 79.86 Days |
|
Days Payable
|
15.39 Days | 60.92 Days | 16.02 Days |
|
5yr Average Interest Coverage Ratio
|
2.96 | 92.41 | 3.55 |
|
5yr Avg ROCE
|
22.21 % | 40.34 % | 3.48 % |
|
5yr Avg Operating Profit Margin
|
4.47 % | 18.05 % | 2.31 % |
|
5 yr average Debt to Equity
|
3.15 | 0.05 | 0.07 |
|
5yr CAGR Net Profit
|
17.26 % | n/a | -1.98 % |
|
5yr Average Return on Assets
|
1.61 % | 20.09 % | 1.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.84 % | 65.99 % | 74.62 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.53 % |
|
Change in Promoter Holding (3 Yrs)
|
8.16 % | -6.87 % | 0.72 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Halder Venture
|
Balaxi Pharma.
|
Parshva Enterprises
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|